Venture firms New Enterprise Associates (NEA) and Kleiner Perkins Caufield and Perkins (KPCB) have raised $20m in a series C round for life sciences startup 3-V Biosciences. Originally based in Zurich, Switzerland, 3-V has since relocated to Silicon Valley in 2010. The startup maintains close ties with the University of Zurich and the Swiss Federal…
3-V Biosciences’ enterprising $20m
Jul 1, 2013 •
LEADERSHIP SOCIETYInforming, connecting, and transforming the global corporate venture capital ecosystem.
The Global Corporate Venturing (GCV) Leadership Society’s mission is to help bridge the different strengths and ambitions of investors across industry sectors, geography, structure, and their returns.
More featured content
Resistance is futile: seven superconductor companies that want to change the world
From healthcare to fusion to quantum computing to space, superconductors have the potential to revolutionise the world. And the technology is finally ready to commercialise.
UK universities urged to lower spinout stakes
A new report recommends stakes of less than 25% but fails to address the issue of access to early-stage capital.
Feb 7, 2024
Mar 14, 2024
Monterey, CA (USA)
Jun 26, 2024